Efficacy and Safety of ARMS versus Stretta in GERD

The comparison of **Anti-Reflux Mucosectomy (ARMS)** and **Radiofrequency Ablation (Stretta)** for the treatment of **Gastroesophageal Reflux Disease (GERD)** highlights differences in efficacy and safety profiles. Here's a detailed breakdown based on the systematic review and meta-analysis:

### **Efficacy**

Both ARMS and Stretta are effective in managing GERD, as evidenced by their ability to:

1. **Reduce GERD Symptoms**:

• Both procedures significantly alleviate GERD-related symptoms, improving patients' quality of life.

2. **Improve GERD-Health Related Quality of Life (GERD-HRQL) Scores**:

• Patients undergoing either ARMS or Stretta report significant improvements in GERD-HRQL scores, indicating better disease management and symptom control.

3. **Lower DeMeester Scores**:

• Both procedures effectively reduce DeMeester scores, which measure acid exposure in the esophagus, reflecting improved acid control.

4. **Reduce Proton Pump Inhibitor (PPI) Dependence**:

• Both ARMS and Stretta help reduce or eliminate the need for long-term PPI therapy, which is a common goal in GERD management.

### **Safety**

While both procedures are effective, their safety profiles differ significantly:

1. **Adverse Events with ARMS**:

• ARMS is associated with a **higher risk of complications** compared to Stretta. The procedure carries risks such as:
• **Perforation**: A serious complication involving a tear in the esophagus.
• **Bleeding**: Increased risk due to the mucosal resection process.
• **Strictures**: Narrowing of the esophagus as a result of scarring.
• **Overall Morbidity**: Higher rates of procedure-related complications.

2. **Safety Profile of Stretta**:

• Stretta demonstrates a **more favorable safety profile** with fewer adverse events. As a less invasive procedure, it is generally associated with minimal complications, making it a safer option for many patients.

### **Clinical Implications**

• **ARMS**:
• May be considered in cases where a more aggressive approach is warranted, but the risk of complications must be carefully weighed.
• Requires close monitoring and expertise due to the higher likelihood of adverse events.

• **Stretta**:
• Offers a safer alternative with a lower risk of complications.
• Preferred in patients where safety is a primary concern, such as those with comorbidities or higher surgical risks.

### **Conclusion**

Both ARMS and Stretta are effective in managing GERD, but **Stretta** is favored in terms of safety. The choice between the two should be individualized, considering the patient's specific condition, risk tolerance, and the expertise of the treating physician.